sapien Search Results


86
Edwards Lifesciences Inc sapien 3 ultra
Sapien 3 Ultra, supplied by Edwards Lifesciences Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sapien 3 ultra/product/Edwards Lifesciences Inc
Average 86 stars, based on 1 article reviews
sapien 3 ultra - by Bioz Stars, 2026-06
86/100 stars
  Buy from Supplier

90
JenaValve Technology Inc new-generation devices sapien 3
New Generation Devices Sapien 3, supplied by JenaValve Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/new-generation devices sapien 3/product/JenaValve Technology Inc
Average 90 stars, based on 1 article reviews
new-generation devices sapien 3 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
CoreValve Inc sapien-xt, no. (%) 31
Procedural characteristics of TAVR.
Sapien Xt, No. (%) 31, supplied by CoreValve Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sapien-xt, no. (%) 31/product/CoreValve Inc
Average 90 stars, based on 1 article reviews
sapien-xt, no. (%) 31 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
CoreValve Inc sapien
Procedural and outcome variation by valve platform.
Sapien, supplied by CoreValve Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sapien/product/CoreValve Inc
Average 90 stars, based on 1 article reviews
sapien - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
CoreValve Inc edwards sapien valve
Procedural and outcome variation by valve platform.
Edwards Sapien Valve, supplied by CoreValve Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/edwards sapien valve/product/CoreValve Inc
Average 90 stars, based on 1 article reviews
edwards sapien valve - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Symetis SA sapienxt
Procedural and outcome variation by valve platform.
Sapienxt, supplied by Symetis SA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sapienxt/product/Symetis SA
Average 90 stars, based on 1 article reviews
sapienxt - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
CoreValve Inc sapien prosthesis
Procedural and outcome variation by valve platform.
Sapien Prosthesis, supplied by CoreValve Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sapien prosthesis/product/CoreValve Inc
Average 90 stars, based on 1 article reviews
sapien prosthesis - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
CoreValve Inc sapien valve size
Procedural and outcome variation by valve platform.
Sapien Valve Size, supplied by CoreValve Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sapien valve size/product/CoreValve Inc
Average 90 stars, based on 1 article reviews
sapien valve size - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
CoreValve Inc tavr valve type bev (sapien xt)
Characteristics of trials included in the metanalysis <xref ref-type= a ." width="250" height="auto" />
Tavr Valve Type Bev (Sapien Xt), supplied by CoreValve Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tavr valve type bev (sapien xt)/product/CoreValve Inc
Average 90 stars, based on 1 article reviews
tavr valve type bev (sapien xt) - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
CoreValve Inc edwards sapien
Characteristics of trials included in the metanalysis <xref ref-type= a ." width="250" height="auto" />
Edwards Sapien, supplied by CoreValve Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/edwards sapien/product/CoreValve Inc
Average 90 stars, based on 1 article reviews
edwards sapien - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
CoreValve Inc sapien 3
Characteristics of trials included in the metanalysis <xref ref-type= a ." width="250" height="auto" />
Sapien 3, supplied by CoreValve Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/sapien 3/product/CoreValve Inc
Average 90 stars, based on 1 article reviews
sapien 3 - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
CoreValve Inc tavr sapien
Characteristics of trials included in the metanalysis <xref ref-type= a ." width="250" height="auto" />
Tavr Sapien, supplied by CoreValve Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tavr sapien/product/CoreValve Inc
Average 90 stars, based on 1 article reviews
tavr sapien - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


Procedural characteristics of TAVR.

Journal: The Journal of heart valve disease

Article Title: Evolution of Veterans Affairs Transcatheter Aortic Valve Replacement Program: The First 100 Patients

doi:

Figure Lengend Snippet: Procedural characteristics of TAVR.

Article Snippet: ​ Percutaneous Transfemoral, No. (%) 90 Cutdown Transfemoral, No. (%) * 8 Transapical, No. (%) ** 2 Valve Platform SAPIEN, No. (%) 16 SAPIEN-XT, No. (%) 31 Corevalve, No. (%) 16 SAPIEN-3, No. (%) 23 Corevalve Evolut-R, No. (%) 14 Anaesthesia General, No. (%) 80 Monitored Anaesthesia Care, No. (%) 20 Hybrid Procedures Percutaneous Coronary Intervention, No. (%) 2 Carotid Stenting, No. (%) 1 Iliac Stenting, No. (%) 2 Endovascular Aortic Repair, No. (%) 1 Open in a separate window * In the group that underwent surgical cutdown for transfemoral access, seven received SAPIEN and one received Corevalve.

Techniques:

Procedural and outcome variation by valve platform.

Journal: The Journal of heart valve disease

Article Title: Evolution of Veterans Affairs Transcatheter Aortic Valve Replacement Program: The First 100 Patients

doi:

Figure Lengend Snippet: Procedural and outcome variation by valve platform.

Article Snippet: Percutaneous Transfemoral, No. (%) 90 Cutdown Transfemoral, No. (%) * 8 Transapical, No. (%) ** 2 Valve Platform SAPIEN, No. (%) 16 SAPIEN-XT, No. (%) 31 Corevalve, No. (%) 16 SAPIEN-3, No. (%) 23 Corevalve Evolut-R, No. (%) 14 Anaesthesia General, No. (%) 80 Monitored Anaesthesia Care, No. (%) 20 Hybrid Procedures Percutaneous Coronary Intervention, No. (%) 2 Carotid Stenting, No. (%) 1 Iliac Stenting, No. (%) 2 Endovascular Aortic Repair, No. (%) 1 Open in a separate window * In the group that underwent surgical cutdown for transfemoral access, seven received SAPIEN and one received Corevalve.

Techniques:

Procedural characteristics of TAVR.

Journal: The Journal of heart valve disease

Article Title: Evolution of Veterans Affairs Transcatheter Aortic Valve Replacement Program: The First 100 Patients

doi:

Figure Lengend Snippet: Procedural characteristics of TAVR.

Article Snippet: Percutaneous Transfemoral, No. (%) 90 Cutdown Transfemoral, No. (%) * 8 Transapical, No. (%) ** 2 Valve Platform SAPIEN, No. (%) 16 SAPIEN-XT, No. (%) 31 Corevalve, No. (%) 16 SAPIEN-3, No. (%) 23 Corevalve Evolut-R, No. (%) 14 Anaesthesia General, No. (%) 80 Monitored Anaesthesia Care, No. (%) 20 Hybrid Procedures Percutaneous Coronary Intervention, No. (%) 2 Carotid Stenting, No. (%) 1 Iliac Stenting, No. (%) 2 Endovascular Aortic Repair, No. (%) 1 Open in a separate window * In the group that underwent surgical cutdown for transfemoral access, seven received SAPIEN and one received Corevalve.

Techniques:

Characteristics of trials included in the metanalysis <xref ref-type= a ." width="100%" height="100%">

Journal: Frontiers in Cardiovascular Medicine

Article Title: The safety and efficacy of balloon-expandable versus self-expanding trans-catheter aortic valve replacement in high-risk patients with severe symptomatic aortic stenosis

doi: 10.3389/fcvm.2023.1130354

Figure Lengend Snippet: Characteristics of trials included in the metanalysis a .

Article Snippet: TAVR valve type , BEV (Sapien XT) vs. SEV (Corevalve) , BEV (Sapien 3) vs. SEV (Corevalve) , BEV (Sapien 3) vs. Acurate neo (SEV) , BEV (Sapien XT, Sapien 3) vs. SEV (Corevalve (83%), Evolut R (17%), Other non BEV was used in 5 patients) , BEV (Sapien 3) vs. SEV (Evolut R/Pro/Portico) , BEV (Sapien 3) vs. SEV (Evolut R).

Techniques:

Comparison of balloon expandable platform vs. self-expanding platforms in high risk patients undergoing TAVR, BEV is associated with reduced risk of all-cause mortality at 30 days compared with SEV ( A ). The sub-group difference was not significant when the studies were stratified for the type of study ( B ). BEV, balloon expandable valve; SEV, self-expanding valve; TAVR, transcatheter aortic valve replacement; M-H, Mantel-Haenszel; CI, confidence interval.

Journal: Frontiers in Cardiovascular Medicine

Article Title: The safety and efficacy of balloon-expandable versus self-expanding trans-catheter aortic valve replacement in high-risk patients with severe symptomatic aortic stenosis

doi: 10.3389/fcvm.2023.1130354

Figure Lengend Snippet: Comparison of balloon expandable platform vs. self-expanding platforms in high risk patients undergoing TAVR, BEV is associated with reduced risk of all-cause mortality at 30 days compared with SEV ( A ). The sub-group difference was not significant when the studies were stratified for the type of study ( B ). BEV, balloon expandable valve; SEV, self-expanding valve; TAVR, transcatheter aortic valve replacement; M-H, Mantel-Haenszel; CI, confidence interval.

Article Snippet: TAVR valve type , BEV (Sapien XT) vs. SEV (Corevalve) , BEV (Sapien 3) vs. SEV (Corevalve) , BEV (Sapien 3) vs. Acurate neo (SEV) , BEV (Sapien XT, Sapien 3) vs. SEV (Corevalve (83%), Evolut R (17%), Other non BEV was used in 5 patients) , BEV (Sapien 3) vs. SEV (Evolut R/Pro/Portico) , BEV (Sapien 3) vs. SEV (Evolut R).

Techniques: Comparison

Comparison of balloon expandable platform with old generation self-expanding platforms for to assess the role of study type (RCTs comparing BEV vs. SEV head to head with post-hoc and pre-specified analyses of RCTs) showing no between-the-group difference on the result. BEV, balloon expandable valve; SEV, self-expanding valve; TAVR, trans-catheter aortic valve replacement; M-H, Mantel-Haenszel; CI, confidence interval.

Journal: Frontiers in Cardiovascular Medicine

Article Title: The safety and efficacy of balloon-expandable versus self-expanding trans-catheter aortic valve replacement in high-risk patients with severe symptomatic aortic stenosis

doi: 10.3389/fcvm.2023.1130354

Figure Lengend Snippet: Comparison of balloon expandable platform with old generation self-expanding platforms for to assess the role of study type (RCTs comparing BEV vs. SEV head to head with post-hoc and pre-specified analyses of RCTs) showing no between-the-group difference on the result. BEV, balloon expandable valve; SEV, self-expanding valve; TAVR, trans-catheter aortic valve replacement; M-H, Mantel-Haenszel; CI, confidence interval.

Article Snippet: TAVR valve type , BEV (Sapien XT) vs. SEV (Corevalve) , BEV (Sapien 3) vs. SEV (Corevalve) , BEV (Sapien 3) vs. Acurate neo (SEV) , BEV (Sapien XT, Sapien 3) vs. SEV (Corevalve (83%), Evolut R (17%), Other non BEV was used in 5 patients) , BEV (Sapien 3) vs. SEV (Evolut R/Pro/Portico) , BEV (Sapien 3) vs. SEV (Evolut R).

Techniques: Comparison

Comparison of balloon expandable platform vs. self-expanding platforms for cardiovascular mortality ( A ), stroke ( B ) and early safety ( C ) at 30 days in high risk patients undergoing TAVR. BEV, balloon expandable valve; SEV, self-expanding valve; TAVR, transcatheter aortic valve replacement; M-H, Mantel-Haenszel; CI, confidence interval.

Journal: Frontiers in Cardiovascular Medicine

Article Title: The safety and efficacy of balloon-expandable versus self-expanding trans-catheter aortic valve replacement in high-risk patients with severe symptomatic aortic stenosis

doi: 10.3389/fcvm.2023.1130354

Figure Lengend Snippet: Comparison of balloon expandable platform vs. self-expanding platforms for cardiovascular mortality ( A ), stroke ( B ) and early safety ( C ) at 30 days in high risk patients undergoing TAVR. BEV, balloon expandable valve; SEV, self-expanding valve; TAVR, transcatheter aortic valve replacement; M-H, Mantel-Haenszel; CI, confidence interval.

Article Snippet: TAVR valve type , BEV (Sapien XT) vs. SEV (Corevalve) , BEV (Sapien 3) vs. SEV (Corevalve) , BEV (Sapien 3) vs. Acurate neo (SEV) , BEV (Sapien XT, Sapien 3) vs. SEV (Corevalve (83%), Evolut R (17%), Other non BEV was used in 5 patients) , BEV (Sapien 3) vs. SEV (Evolut R/Pro/Portico) , BEV (Sapien 3) vs. SEV (Evolut R).

Techniques: Comparison

Comparison of balloon expandable platform vs. self-expanding platforms for implantation of >1 valve per procedure ( A ), moderate to severe AR/PVL ( B ), new PPM requirement ( C ), and device success as defined by VARC ( D ) at 30 days in high risk patients undergoing TAVR. BEV, balloon expandable valve; SEV, self-expanding valve; AR, aortic regurgitation; PVL, para valvular leak; PPM, permanent pacemaker; TAVR, transcatheter aortic valve replacement; VARC, valve academic research consortium; M-H, Mantel-Haenszel; CI, confidence interval.

Journal: Frontiers in Cardiovascular Medicine

Article Title: The safety and efficacy of balloon-expandable versus self-expanding trans-catheter aortic valve replacement in high-risk patients with severe symptomatic aortic stenosis

doi: 10.3389/fcvm.2023.1130354

Figure Lengend Snippet: Comparison of balloon expandable platform vs. self-expanding platforms for implantation of >1 valve per procedure ( A ), moderate to severe AR/PVL ( B ), new PPM requirement ( C ), and device success as defined by VARC ( D ) at 30 days in high risk patients undergoing TAVR. BEV, balloon expandable valve; SEV, self-expanding valve; AR, aortic regurgitation; PVL, para valvular leak; PPM, permanent pacemaker; TAVR, transcatheter aortic valve replacement; VARC, valve academic research consortium; M-H, Mantel-Haenszel; CI, confidence interval.

Article Snippet: TAVR valve type , BEV (Sapien XT) vs. SEV (Corevalve) , BEV (Sapien 3) vs. SEV (Corevalve) , BEV (Sapien 3) vs. Acurate neo (SEV) , BEV (Sapien XT, Sapien 3) vs. SEV (Corevalve (83%), Evolut R (17%), Other non BEV was used in 5 patients) , BEV (Sapien 3) vs. SEV (Evolut R/Pro/Portico) , BEV (Sapien 3) vs. SEV (Evolut R).

Techniques: Comparison

Comparison of balloon expandable platform vs. self-expanding platforms for life-threatening bleeding ( A ), major vascular complications ( B ), acute kidney injury ( C ), and atrial fibrillation ( D ) at 30 days in high risk patients undergoing TAVR. BEV, balloon expandable valve; SEV, self-expanding valve; TAVR, transcatheter aortic valve replacement; M-H, Mantel-Haenszel; CI, confidence interval.

Journal: Frontiers in Cardiovascular Medicine

Article Title: The safety and efficacy of balloon-expandable versus self-expanding trans-catheter aortic valve replacement in high-risk patients with severe symptomatic aortic stenosis

doi: 10.3389/fcvm.2023.1130354

Figure Lengend Snippet: Comparison of balloon expandable platform vs. self-expanding platforms for life-threatening bleeding ( A ), major vascular complications ( B ), acute kidney injury ( C ), and atrial fibrillation ( D ) at 30 days in high risk patients undergoing TAVR. BEV, balloon expandable valve; SEV, self-expanding valve; TAVR, transcatheter aortic valve replacement; M-H, Mantel-Haenszel; CI, confidence interval.

Article Snippet: TAVR valve type , BEV (Sapien XT) vs. SEV (Corevalve) , BEV (Sapien 3) vs. SEV (Corevalve) , BEV (Sapien 3) vs. Acurate neo (SEV) , BEV (Sapien XT, Sapien 3) vs. SEV (Corevalve (83%), Evolut R (17%), Other non BEV was used in 5 patients) , BEV (Sapien 3) vs. SEV (Evolut R/Pro/Portico) , BEV (Sapien 3) vs. SEV (Evolut R).

Techniques: Comparison